Health Care & Life Sciences » Medical Equipment & Supplies | Quidel Corp.

Quidel Corp. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
7,390.00
7,074.00
6,079.00
13,808.00
8,165.00
74,183
Depreciation, Depletion & Amortization
24,694.00
28,365.00
23,386.00
22,796.00
30,762.00
46,266
Other Funds
1,399.00
2,112.00
213.00
207.00
497.00
17,716
Funds from Operations
36,863.00
28,548.00
25,704.00
19,356.00
51,522.00
138,165
Changes in Working Capital
11,181.00
9,296.00
7,541.00
7,604.00
23,813.00
2,333
Net Operating Cash Flow
25,682.00
37,844.00
33,245.00
11,752.00
27,709.00
135,832
Capital Expenditures
22,501.00
11,241.00
17,032.00
11,909.00
17,510.00
Net Investing Cash Flow
33,935.00
11,241.00
17,032.00
16,970.00
431,759.00
Issuance/Reduction of Debt, Net
5,380.00
167,347.00
509.00
4,999.00
246,220.00
Net Financing Cash Flow
1,790.00
168,060.00
28,684.00
16,799.00
270,608.00
Net Change in Cash
6,468.00
194,665.00
12,488.00
22,026.00
133,422.00
Free Cash Flow
4,861.00
26,695.00
16,277.00
157.00
10,199.00
Deferred Taxes & Investment Tax Credit
1,928.00
2,744.00
4,027.00
2,603.00
-
-
Net Assets from Acquisitions
11,434.00
-
-
5,061.00
414,249.00
Change in Capital Stock
5,771.00
2,825.00
28,023.00
11,593.00
24,885.00
Exchange Rate Effect
5.00
2.00
17.00
9.00
20.00

About Quidel

View Profile
Address
12544 High Bluff Drive
San Diego California 92130
United States
Employees -
Website http://www.quidel.com
Updated 07/08/2019
Quidel Corp. engages in the development, manufacture, and market of rapid diagnostic testing solutions. Its portfolio includes immunoassays, molecular diagnostics, virology, and specialty products. Immunoassay tests are for physician offices, hospital laboratories, emergency departments, pharmacies, and other urgent care or alternative site settings.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.